Adamas Pharmaceuticals Inc (NASDAQ:ADMS) saw its shares crater by as much as 21% today on exceptionally high volume. This drop was triggered by …
Adamas Pharmaceuticals Inc (NASDAQ:ADMS) is a mover and shaker out on the Street today, with investors sparking the stock on an almost 19% …
Analyst nearly doubles price target between Gocovri pricing and better prospects in Multiple Sclerosis arena.
Lead asset for ADMS indicates promising prospects in Parkinson’s along with valuable opportunity in MS.
Adamas Puts CRL Fears to Rest with Gocovri (Amantadine) Approval
A Peek Into Three Volatile Biotech Stocks: ADMS, XOMA, KMDA
Adamas Pharmaceuticals Inc (NASDAQ:ADMS) investors are busy throwing a party this evening, following the news that the drug maker has won FDA approval …
Adamas Pharmaceuticals Inc (NASDAQ:ADMS) saw its shares slipping nearly 17% this month ahead of the August 24 PDUFA date for ADS-5102 in the …
